Biology Reference
In-Depth Information
44. Nagy E, Berczi I. Pituitary dependence of bone marrow function. Br J Haematol
1989;71:457-62.
45. Nagy E, Berczi I. Prolactin and contact sensitivity. Allergy 1981;36:429-31.
46. Nagy E, Berczi I, Friesen HG. Regulation of immunity in rats by lactogenic and growth
hormones. Acta Endocrinol 1983;102:351-57.
47. Berczi I, Nagy E, Kovacs K, Horvath E. Regulation of humoral immunity in rats by pitu-
itary hormones. Acta Endocrinol 1981;98:506-13.
48. Berczi I, Nagy E, Asa SL, Kovacs K. Pituitary hormones and contact sensitivity in rats.
Allergy 1983;38:325-30.
49. Berczi I, Nagy E, Matusik RJ, Friesen HG. Pituitary hormones regulate c-myc and DNA
synthesis in lymphoid tissue. J Immunol 1991;146:2201-6.
50. Horseman ND, Zhao W, Montecino-Rodrigez E, Tanaka M, Nakashima K, Engle SJ, et al.
Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of
the prolactin gene. EMBO J 1997;16:6926-35.
51. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor:
actions, signal transduction pathways and phenotypes observed in PRL-receptor knockout
mice. Endocrine Rev 1998;19:225-68.
52. Kaplan SL, Grumbach MM, Friesen HG, Costom BH. Thyrotropin-releasing factor (TRF)
effect on secretion of human pituitary prolactin and thyrotropin in children and in idio-
pathic hypopituitary dwarfism: further evidence for hypophysiotropic hormone deficien-
cies. J Clin Endocrinol Metab 1972;35:825-30.
53. Sinha YN, Salocks CB, Vanderlaan WP. Pituitary and serum concentrations of prolactin
and GH in Snell dwarf mice. Proc Soc Exp Biol Med 1975;150(1):207-10.
54. Pfaffle RW, Blankenstein O, Wuller S, Kentrup H. Combined pituitary hormone defi-
ciency: role of Pit-1 and Prop-1. Acta Paediatr Suppl 1999;88(433):33-41.
55. Sinha YN, Vanderlaan WP. Effect on growth of prolactin deficiency induced in infant
mice. Endocrinology 1982;110(6):1871-78.
56. Nagy E, Berczi I, Wren GE, Asa SL, Kovacs K. Immunomodulation by bromocriptine.
Immunopharmacology 1983;6:231-43.
57. Nagy E, Berczi I. Hypophysectomized rats depend on residual prolactin for survival.
Endocrinology 1991;128:2776-84.
58. Potter EL, Craig JM. Pathology of the fetus and the infant. 3rd ed. Chicago: Year Book; 1975.
59. DiMattia GE, Gellersen B, Duckworth ML, Friesen HG. Human prolactin gene expres-
sion: the use of an alternative noncoding exon in decidua and the IM-9_P3 lymphoblas-
toid cell line. J Biol Chem 1990;265:16412-21.
60. Watanabe K, Kessler CA, Bachurski CJ, Kanda Y, Richardson BD, Stanek J, et al.
Identification of a decidua-specific enhancer on the human prolactin gene with two criti-
cal activator protein 1 (AP-1) binding sites. Mol Endocrinol 2001;15(4):638-53.
61. Nagafuchi H, Suzuki N, Kaneko A, Asai T, Sakane T. Prolactin locally produced by syn-
ovium infiltrating T lymphocytes induces excessive synovial cell functions in patients
with rheumatoid arthritis. J Rheumatol 1999;26:1890-900.
62. Warren JL. Type I cytokines, interferons and their receptors. In: Paul WE, editor.
Fundamental immunology. 4th ed. New York: Lippincott-Raven; 1999. p. 741-74.
63. Venkatesh J, Peeva E, Xu X, Diamond B. Cutting edge: hormonal milieu, not anti-
genic specificity, determines the mature phenotype of autoreactive B cells. J Immunol
2006;176:3311.
64. Selye H. The mast cells. Reading, MA: Butterworth; 1965.
65. Ishizaka K, Ishizaka T. Identification of gamma-E-antibodies as a carrier of reaginic activ-
ity. J Immunol 1967;99(6):1187-98.
